ATM gene mutations are not involved in medulloblastoma in children

Cancer Genetics and Cytogenetics

Volumn 146, Issue 2, 2003, Pages 167-169

  Liberzon, Ella ^a   Avigad, Smadar ^a   Cohen, Ian J ^a   Yaniv, Isaac ^a   Michovitz, Shalom ^a   Zaizov, Rina ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CANCER SCREENING; CHILD; CHROMOSOME 11Q; CLINICAL ARTICLE; CONTROLLED STUDY; GENE DELETION; GENE MUTATION; GENETIC POLYMORPHISM; HETEROZYGOSITY LOSS; HUMAN; INFANT; MEDULLOBLASTOMA; PATHOGENESIS; PEDIATRICS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; WILD TYPE;

ATAXIA; ATAXIA TELANGIECTASIA;

EID: 0141862122     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(03)00130-4     Document Type: Article

References (21)

1. Lewin V.A., Leibel S.A., Gutin P.H. Neoplasms of the central nervous systems. DeVita V.T. Jr., Hellman A., Rosenberg S.A. Cancer, principles and practice of oncology. 6th ed:2001;2100-2158 Lippincott Williams & Wilkins, Philadelphia.
2. Biegel J.A., Rorke L.B., Packer R.J., Sutton L.N., Schut L., Bonner K., Emanuel B.S. Isochromosome 17q in primitive neuroectodermal tumors of the central nervous system. Genes Chromosomes Cancer. 1:1989;139-147.
3. Reardon D.A., Michalkiewicz E., Boyett J.M., Sublett J.E., Entrekin R.E., Ragsdale S.T., Valentine M.B., Behm F.G., Li H., Heideman R.L., Kun L.E., Shapiro D.N., Look A.T. Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridization. Cancer Res. 57:1997;4042-4047.
4. Scheurlen W.G., Schwabe G.C., Joos S., Mollenhauer J., Sorensen N., Kuhl J. Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome. J Clin Oncol. 16:1998;2478-2485.
5. Yin X.-L., Pang J.C., Liu Y.-H., Chong E.Y., Cheng Y., Poon W.-S., Ng H.-K. Analysis of loss of heterozygosity on chromosomes 10q, 11, and 16 in medulloblastoma. J Neurosurg. 94:2001;799-805.
6. Michiels E.M., Weiss M.M., Hoovers J.M., Baak J.P., Voute P.A., Baas F., Hermsen M.A. Genetic alterations in childhood medulloblastoma analyzed by comparative genomic hybridization. J Pediatr Hematol Oncol. 24:2002;205-210.
7. Shiloh Y. ATM and ATR: networking cellular responses to DNA damage. Curr Opin Genet Dev. 11:2001;71-77.
8. Taylor A.M.R., Metcalfe J.A., Thick J., Mak Y.-F. Leukemia and lymphoma in ataxia telangiectasia. Blood. 87:1996;423-438.
9. Savitsky K., Bar-Shira A., Gilad S., Rotman G., Ziv Y., Vanagaite L., Tagle D.A., Smith S., Uziel T., Sfez S., Ashkenazi M., Pecker I., Frydman M., Harnik R., Pantanjali S.R., Simmons A., Clines G.A., Sartiel A., Gatti R.A., Chessa L., Sanal O., Lavin M.F., Jaspers N.G.J., Taylor A.M.R., Arlett C.F., Miki T., Weissman S.M., Lovett M., Collins F.S., Shiloh Y. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science. 268:1995;1749-1753.
10. Meyn M.S. Ataxia-telangiectasia, cancer and the pathobiology of the ATM gene. Clin Genet. 55:1999;289-304.
11. Hecht F., Hecht B.K. Cancer in ataxia-telangiectasia patients. Cancer Genet Cytogenet. 46:1990;9-19.
12. Shuster J., Hart Z., Stimson C.W., Brough A.J., Poulik M.D. Ataxia-telangiectasia with cerebellar tumor. Pediatrics. 37:1966;776.
13. Hart R.M., Kimler B.F., Evans R.G., Park C.H. Radiotherapeutic management of medulloblastoma in a pediatric patient with ataxia telangiectasia. Int J Radiat Oncol Biol Phys. 13:1987;1237-1240.
14. Groot-Loonen J.J., Slater R., Taminiau J., Voute P.A. Three consecutive primary malignancies in one patient during childhood. Pediatr Hematol Oncol. 5:1988;287-292.
15. Miyagi K., Mukawa J., Kinjo N., Horikawa K., Mekaru S., Nakasone S., Koga H., Higa Y., Naito M. Astrocytoma linked to familial ataxia telangiectasia. Acta Neurochir (Wien). 135:1995;87-92.
16. Kukita Y., Tahira T., Sommer S.S., Hayashi K. SSCP analysis of long DNA fragments in low pH gel. Hum Mutat. 10:1997;400-407.
17. Thorstenson Y.R., Shen P., Tusher V.G., Wayne T.L., Davis R.W., Chu G., Oefner P.J. Global analysis of ATM polymorphism reveals significant functional constraint. Am J Hum Genet. 69:2001;396-412.
18. Dork T., Bendix R., Bremer M., Rades D., Klopper K., Nicke M., Skawran B., Hector A., Yamini P., Steinmann D., Weise S., Stuhrmann M., Karstens J.H. Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients. Cancer Res. 61:2001;7608-7615.
19. Stankovic T., Stewart G.S., Byrd P., Fegan C., Moss P.A.H., Taylor A.M.R. ATM mutations in sporadic lymphoid tumours. Leuk Lymphoma. 43:2002;1563-1571.
20. Oka A., Takashima S. Expression of the ataxia-telangiectasia gene (ATM) product in human cerebellar neurons during development. Neurosci Lett. 252:1998;195-198.
21. Chen G., Lee E.Y.H.P. The product of the ATM gene is a 370-kDa nuclear phosphoprotein. J Biol Chem. 271:1996;33693-33697.